Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Genmab A/S - ADR have a median target of 38.00, with a high estimate of 51.00 and a low estimate of 25.00. The median estimate represents a 64.64% increase from the last price of 23.08.
High | 121.0% | 51.00 |
Med | 64.6% | 38.00 |
Low | 8.3% | 25.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 12, 2025.
Average growth rate | +9.85% |
Average growth rate | -17.13% |
More ▼
Revenue history & estimates in USD
Average growth rate | +5.18% |
Average growth rate | +37.08% |
More ▼